Annual Drug Patent Expirations for AKYNZEO
Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It’s out there from one provider. There are eighteen patents defending this drug.
This drug has 200 and thirty patent relations in sixty-eight international locations.
The generic ingredient in AKYNZEO is fosnetupitant chloride hydrochloride; palonosetron hydrochloride. One provider is listed for this compound. Further particulars can be found on the fosnetupitant chloride hydrochloride; palonosetron hydrochloride profile web page.
For extra data on how DrugPatentWatch may help along with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially printed at New patent for Helsinn Hlthcare drug AKYNZEO